category:news A glowing endorsement of GLP1s by cardiologists Reflection on the ACC's endorsement of GLP1s as a first-line approach to weight management and improving cardiovascular outcomes.
category:benefits GLP1s lower inflammation, Psoriasis, AND increase fertility? We look into the anti-inflammatory effects of GLP1s and their effects on issues like psoriasis and infertility.
category:news Oral pill Orforglipron delivers stellar results in Phase 3 Trial Eli Lilly's new drug oral GLP1 Orforglipron delivers fantastic results in phase 3 trial -- 7.6% weight loss for just a pill!
category:watercooler GLP1 use by younger people We dig into the reports of younger people using GLP1s like Ozempic, Wegovy and others.
category:benefits Zepbound coverage for Sleep Apnea gets Agency approval Center for Medicare and Medicaid declared that Zepbound is covered by insurance for treating Sleep Apnea, given it's effectiveness.
research Research suggesting GLP1 is a brain drug Why has modern scientific opinion shifted to GLP1 being a brain drug rather than a gut drug? We dive into the critical research paper supporting the shift.
categeory:watercooler Research models applied to GLP1s and Plateaus New research that shows a benefit to appetite feedback control circuits via mathematical modeling, showing the benefits of using GLP1s.
country:uk The UK's bet on GLP1 A look at the UK's growing evaluation and use of GLP1 receptor agonists -- Ozempic, Mounjaroy, Wegovy, Zepbound and more.
category:news GLP1s and Sleep Apnea GLP1s (in particular Tirzepatide, created by Eli Lilly) have positive effects on Sleep Apnea
chemical:semaglutide 24% Less kidney disease risk with Semaglutide (Ozempic) Can we trust research funded by Novo Nordisk which found a 24% decrease in kidney disease risk for people on Semaglutide (Ozempic)?
